June 7, 2009 Is FDA Bipolar or Complicit in Legitimizing Illegal Marketing?FDA officials are ignoring the real world tragedies–drug-induced deaths of children. Unfortunately for the children, child psychiatrists Read More Is FDA Bipolar or Complicit in Legitimizing Illegal Marketing?
June 4, 2009 Marketing Trumps Safety: the case of AntipsychoticsJust as the FDA is convening an advisory committee hearing (June 9-10) about whether to expand the Read More Marketing Trumps Safety: the case of Antipsychotics
May 29, 2009 Rx for Antipsychotc Drugs for Children Begin To Decelerate_WSJSunshine is the great disinfectant! The Wall Street Journal reports that antipsychotic drug prescriptions for children–which the Read More Rx for Antipsychotc Drugs for Children Begin To Decelerate_WSJ
May 8, 2009 Has the Obama administration already cowered to the demands of Big Pharma?The unexpected approval of a "me too" dangerous antipsychotic drug that the agency itself had deemed "NOT Read More Has the Obama administration already cowered to the demands of Big Pharma?
May 7, 2009 Title: FDA Approves Antipsychotic With Long History of Failure"Hoechst Marion Roussel Inc. made initial inquiries into the drug; however, in May 1996, they discontinued research, Read More Title: FDA Approves Antipsychotic With Long History of Failure
April 20, 2009 AHRP Letter to Harvard Re: Dr. Biederman’s ResearchALLIANCE FOR HUMAN RESEARCH PROTECTION A catalyst for public debate 142 West End Avenue Suite 28P New Read More AHRP Letter to Harvard Re: Dr. Biederman’s Research
March 30, 2009 Florida Antipsychotic Pre-Approval Requirement Protects PreschoolChildrenThe State of Florida has established a pre-approval requirement to protect preschool children on Medicaid from being Read More Florida Antipsychotic Pre-Approval Requirement Protects PreschoolChildren
February 27, 2009 AstraZeneca: “Smoke-and-Mirror Jobâ€The lid of another pharmaceutical company’s Pandora Box has been lifted: Lawyers agreed to unseal most AstraZeneca Read More AstraZeneca: “Smoke-and-Mirror Jobâ€
November 24, 2008 Biederman J & J Risperdal DocumentsA group of internal emails by Johnson & Johnson officials-mostly from officials in the company’s Risperdal marketing Read More Biederman J & J Risperdal Documents
November 24, 2008 Biederman J & J Risperdal DocumentsThe New York Times reports (below) "Dr. Biederman’s work helped to fuel a 40-fold increase from 1994 Read More Biederman J & J Risperdal Documents
November 18, 2008 Antipsychotic Use in Children: FDA Panel Rejects FDA Soft-Peddle ApproachThe New York Times reports that an FDA advisory committee deliberating over the safety of using antipsychotic Read More Antipsychotic Use in Children: FDA Panel Rejects FDA Soft-Peddle Approach
November 30, 2007 Letter of Complaint to FDA Commissioner, 2007 ALLIANCE FOR HUMAN RESEARCH PROTECTION www.ahrp.org 142 West End Avenue, Suite 28P New York, NY Read More Letter of Complaint to FDA Commissioner, 2007
February 25, 2007 Activists Take on Eli Lilly Over Off-Label Marketing & Harm Caused by ZyprexaEvelyn Pringle reports (below) that the group is also supporting Jim Gottstein in his battle with Eli Read More Activists Take on Eli Lilly Over Off-Label Marketing & Harm Caused by Zyprexa